Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Jun 15, 2021; 13(6): 589-599
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.589
Table 3 Postoperative characteristics, adverse events (classification and treatment), readmission, and deaths
Postoperative characteristics (n = 14)
n (%)
Clavien-Dindo
Abdominal drain14 (100)-
Surgical site (adverse events)4 (28.5)-
Surgical wound infection (PD)1 (7.1)II (Antibiotic)
Transient liver failure/ascites (PD)1 (7.1)I
Grade C pancreatic fistula (CCP); Grade B pancreatic fistula (CCP) 1 (7.1); 1 (7.1)III (EL); II (abdominal drain)
Surgical site (adverse events outside)1 (7.1)
Urinary infection (PD)1 (7.1)II (Antibiotic)
Readmission1 (7.1)Grade C fistula (EL)
Death up to 90 d0